Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Clover Health Investments, Corp. (CLOV)

4.3100 -0.1500 (-3.36%)
At close: November 2 at 4:00:01 PM EST
4.3400 +0.0300 (+0.70%)
Pre-Market: 7:03:15 AM EST
Trade CLOV on Coinbase
CLOV Q3 2026 earnings call
November 4, 2026 at 5 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
2,476,713
1,924,308
1,371,131
1,260,543
1,096,552
Cost of Revenue
2,016,785
1,568,406
1,006,327
1,004,590
993,073
Gross Profit
459,928
355,902
364,804
255,953
103,479
Operating Expense
478,289
441,431
410,265
435,516
390,143
Operating Income
-18,361
-85,529
-45,461
-179,563
-286,664
Net Non Operating Interest Income Expense
--
0
0
-7
-1,363
Other Income Expense
486
-20
-805
-30,578
33,443
Pretax Income
-18,362
-85,549
-46,266
-210,148
-254,584
Net Income Common Stockholders
-18,362
-85,549
-43,009
-213,361
-339,567
Diluted NI Available to Com Stockholders
-18,362
-85,549
-43,009
-213,361
-339,567
Basic EPS
-0.04
-0.17
-0.08
-0.44
-0.71
Diluted EPS
-0.05
-0.17
-0.08
-0.44
-0.71
Basic Average Shares
519,450.8830
511,967.1460
490,018.7300
482,176.1270
476,244.2620
Diluted Average Shares
527,656.4200
511,967.1460
490,018.7300
482,176.1270
476,244.2620
Total Operating Income as Reported
-18,361
-85,529
-45,749
-205,329
-286,664
Total Expenses
2,495,074
2,009,837
1,416,592
1,440,106
1,383,216
Net Income from Continuing & Discontinued Operation
-18,362
-85,549
-43,009
-213,361
-339,567
Normalized Income
-18,361
-85,529
-45,461
-179,570
-288,027
Interest Expense
--
0
0
7
1,363
Net Interest Income
--
0
0
-7
-1,363
EBIT
-18,381
-85,549
-46,266
-210,141
-253,221
EBITDA
-16,476
-83,863
-44,935
-207,632
-252,034
Reconciled Cost of Revenue
2,016,785
1,568,406
1,006,327
1,004,590
993,073
Reconciled Depreciation
1,905
1,686
1,331
2,509
1,187
Net Income from Continuing Operation Net Minority Interest
-18,362
-85,549
-46,266
-210,148
-254,584
Total Unusual Items Excluding Goodwill
-1
-20
-805
-30,578
33,443
Total Unusual Items
-1
-20
-805
-30,578
33,443
Normalized EBITDA
-16,475
-83,843
-44,130
-177,054
-285,477
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 6/12/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: